Table 4.
No. | Gene symbol | Full name | Function |
---|---|---|---|
1 | OPRD1 | Delta-type opioid receptor | Play a role in the perception of pain and in opiate-mediated analgesia and developing analgesic tolerance to morphine. |
2 | AVP | Vasopressin-neurophysin 2-copeptin |
It has a direct antidiuretic action on the kidney; it also causes vasoconstriction of the peripheral vessels. Acts by binding to vasopressin receptors (V1bR/AVPR1B, V1aR/AVPR1A, and V2R/AVPR2) |
3 | BDKRB2 | B2 bradykinin receptor | Associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. |
4 | TAS2R4 | Taste receptor type 2 member 4 | Encode a 7-transmembrane receptor protein, functioning as a bitter taste receptor. |
5 | KNG1 | Kininogen-1 | A mediator of inflammation and causes increase in vascular permeability. |
6 | BDKRB1 | B1 bradykinin receptor | This is a receptor for bradykinin. Could be a factor in chronic pain and inflammation. |
7 | AGT | Angiotensinogen | Essential component of the renin-angiotensin system, a potent regulator of blood pressure, body fluid and electrolyte homeostasis. |
8 | PTGDR2 | Prostaglandin D2 receptor 2 | PI3K signaling is implicated in mediating PTGDR2 effects. |
9 | LPAR6 | Lysophosphatidic acid receptor 6 | Bind to oleoyl-L-alpha-lysophosphatidic acid (LPA). Intracellular cAMP is involved in the receptor activation. |
10 | C5 | Complement C5 | A mediator of local inflammatory process. Binding to the receptor C5AR1 induces a variety of responses including intracellular calcium release, contraction of smooth muscle, increased vascular permeability, and histamine release from mast cells and basophilic leukocytes |
11 | OPRL1 | Nociceptin receptor | Play a role in the regulation of locomotor activity by the neuropeptide nociceptin. |
12 | ADRA2C | Alpha-2C adrenergic receptor | Alpha-2 adrenergic receptors mediate the catecholamine-induced inhibition of adenylate cyclase through the action of G proteins. |
13 | CCL16 | C-C motif chemokine 16 | Shows potent myelosuppressive activity and suppresses proliferation of myeloid progenitor cells. |
14 | OXER1 | Oxoeicosanoid receptor 1 | Receptor for eicosanoids and polyunsaturated fatty acids |
15 | CORT | Cortistatin | Bind to all human somatostatin receptor (SSTR) subtypes. It also inhibits cAMP production induced by forskolin through SSTRs. |
16 | SSTR5 | Somatostatin receptor type 5 | Increases cell growth inhibition activity of SSTR2 following heterodimerization |
17 | PYY | Peptide YY | This gut peptide inhibits exocrine pancreatic secretion, has a vasoconstrictory action, and inhibits jejunal and colonic mobility. |
18 | MCHR1 | Melanin-concentrating hormone receptor 1 | Receptor for melanin-concentrating hormone, coupled to both G proteins that inhibit adenylyl cyclase and G proteins that activate phosphoinositide hydrolysis. |
19 | UTS2R | Urotensin-2 receptor | High affinity receptor for urotensin-2 and urotensin-2B. |
20 | ANXA1 | Annexin A1 | Play important roles in the innate immune response as effector of glucocorticoid-mediated responses and regulator of the inflammatory process. Has anti-inflammatory activity |
21 | ADCY1 | Adenylate cyclase type 1 | Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca2+/calmodulin levels |
22 | GPR68 | Ovarian cancer G-protein coupled receptor 1 | Proton-sensing receptor involved in pH homeostasis. |
23 | PIK3R1 | Phosphatidylinositol 3-kinase regulatory subunit alpha | Modulates the cellular response to ER stress during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement |
24 | P2RY4 | P2Y purinoceptor 4 | Receptor for UTP and UDP coupled to G-proteins that activate a phosphatidylinositol-calcium second messenger system |
25 | HCAR2 | Hydroxycarboxylic acid receptor 2 | Receptor activation by nicotinic acid results in reduced cAMP levels which may affect activity of cAMP-dependent protein kinase A and phosphorylation of target proteins, leading to neutrophil apoptosis. |